Pharmaceuticals - New York, NY, United States
Manhattan Pharmaceuticals, Inc. is a specialty healthcare product company focused on developing and commercializing innovative treatments for underserved patient populations. The current portfolio of product candidates includes: * AST-726 – a nasally delivered form of hydroxocobalamin for the treatment of vitamin B 12 deficiency * Hedrin® – a novel, non-pesticide treatment for pediculosis (head lice) * AST-915 – an oral treatment for essential tremor * GEL – a topical gel for the treatment of mild psoriasisManhattan Pharmaceuticals is located in New York City and is traded on the OTC Bulletin Board® under the ticker symbol "MHAN".
Amazon AWS